Avalyn Pharma Inc.

Pharmaceutical company · Boston, Massachusetts, United States · Nasdaq: AVLN

Avalyn Pharma Inc. is a pharmaceutical company headquartered in Boston, Massachusetts, United States. Its earliest recorded incorporation is in 2011. Its shares trade on Nasdaq under the ticker AVLN. It has reported private securities offerings to the US SEC, most recently $189 million sold in a notice filed in 2023.

Profile compiled from public records. Is this your company? Request a correction or update

Avalyn Pharma at a glance

Typepharmaceutical company
HeadquartersBoston, Massachusetts, United States
Earliest incorporation on record2011
Stock listingNasdaq: AVLN
SEC industryPharmaceutical Preparations
SEC CIK1540171

What does Avalyn Pharma do?

Private fundraising reported to the SEC

7 Form D notices; the most recent reported $189.2 million sold (2023).

Frequently asked questions about Avalyn Pharma

Where is Avalyn Pharma headquartered?

Avalyn Pharma Inc. is headquartered in Boston, Massachusetts, United States.

What does Avalyn Pharma do?

Avalyn Pharma Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.

Is Avalyn Pharma a public company?

Yes. Avalyn Pharma Inc. trades on Nasdaq under the ticker AVLN.

When was Avalyn Pharma founded?

The earliest incorporation on record for Avalyn Pharma Inc. is in 2011, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Sources

Location data: GeoNames (geonames.org), CC BY 4.0.

Last updated 2026-09-23.